Standard Biotools (LAB) Share-based Compensation (2010 - 2026)

Standard Biotools (LAB) has 17 years of Share-based Compensation data on file, last reported at $5.0 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 10771.74% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $22.7 million, a 63.63% increase from a year earlier, with the FY2025 full-year figure at $25.8 million, up 33.54% from the prior year.
• Share-based Compensation for Q1 2026 stood at $5.0 million, up from $4.8 million in the prior quarter.
• Over the last five years, Share-based Compensation for LAB reached as high as $7.5 million in Q3 2025 and fell as low as -$9.5 million in Q4 2023.
• Historically, Share-based Compensation has averaged $2.5 million across 5 years, with a median of $3.4 million in 2024.
• Across the five-year window, Share-based Compensation plunged 665.68% in 2023 and surged 10771.74% in 2026, its largest moves.
• Year by year, Share-based Compensation stood at $1.7 million in 2022, then plunged by 665.68% to -$9.5 million in 2023, then surged by 160.83% to $5.8 million in 2024, then decreased by 16.72% to $4.8 million in 2025, then climbed by 3.82% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $5.0 million in Q1 2026, $4.8 million in Q4 2025, and $7.5 million in Q3 2025.